GE HealthCare, a subsidiary of General Electric, is a leading player in the global healthcare industry, headquartered in the United States. Founded in 1892, the company has evolved significantly, marking key milestones such as the introduction of advanced imaging technologies and innovative patient monitoring systems. With a strong presence in North America, Europe, and Asia, GE HealthCare focuses on medical imaging, monitoring, biomanufacturing, and digital solutions. Its core products, including MRI machines, ultrasound systems, and healthcare IT solutions, are renowned for their cutting-edge technology and reliability. As a pioneer in healthcare innovation, GE HealthCare has consistently maintained a strong market position, recognised for its commitment to improving patient outcomes and operational efficiency in healthcare settings worldwide.
How does GE HealthCare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
GE HealthCare's score of 91 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, GE HealthCare reported total greenhouse gas emissions of approximately 6,064,000,000,000 kg CO2e, with significant contributions from Scope 1, 2, and 3 emissions. Specifically, Scope 1 emissions were about 105,000,000 kg CO2e, while Scope 2 emissions totalled approximately 116,000,000 kg CO2e. The majority of emissions stemmed from Scope 3, which accounted for about 6,064,000,000,000 kg CO2e, primarily from downstream leased assets. GE HealthCare has set ambitious climate commitments, aiming to achieve net-zero greenhouse gas emissions across its value chain by 2050. The company has established interim targets to reduce absolute Scope 1 and 2 emissions by 42% by 2030, using 2022 as the baseline year. Additionally, GE HealthCare plans to cut Scope 3 emissions from purchased goods and services, upstream transportation and distribution, business travel, and the use of sold products by 25% by 2030, also relative to a 2022 baseline. These targets align with the Science Based Targets initiative (SBTi) and reflect GE HealthCare's commitment to sustainable practices within the healthcare equipment and supplies sector. The company is on track to meet its near-term goals, with a long-term vision that includes a 90% reduction in absolute emissions across all scopes by 2050.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 137,254,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 192,207,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 0,000,000,000,000 | 0,000,000,000,000 | 0,000,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GE HealthCare is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
